Glaukos Cash on Hand 2014-2023 | GKOS
Glaukos cash on hand from 2014 to 2023. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Glaukos Annual Cash on Hand (Millions of US $) |
2022 |
$353 |
2021 |
$414 |
2020 |
$404 |
2019 |
$174 |
2018 |
$140 |
2017 |
$119 |
2016 |
$96 |
2015 |
$91 |
2014 |
$2 |
2013 |
$7 |
Glaukos Quarterly Cash on Hand (Millions of US $) |
2023-03-31 |
$318 |
2022-12-31 |
$353 |
2022-09-30 |
$362 |
2022-06-30 |
$391 |
2022-03-31 |
$415 |
2021-12-31 |
$414 |
2021-09-30 |
$429 |
2021-06-30 |
$419 |
2021-03-31 |
$407 |
2020-12-31 |
$404 |
2020-09-30 |
$388 |
2020-06-30 |
$395 |
2020-03-31 |
$164 |
2019-12-31 |
$174 |
2019-09-30 |
$153 |
2019-06-30 |
$150 |
2019-03-31 |
$145 |
2018-12-31 |
$140 |
2018-09-30 |
$138 |
2018-06-30 |
$120 |
2018-03-31 |
$114 |
2017-12-31 |
$119 |
2017-09-30 |
$109 |
2017-06-30 |
$104 |
2017-03-31 |
$99 |
2016-12-31 |
$96 |
2016-09-30 |
$94 |
2016-06-30 |
$94 |
2016-03-31 |
$88 |
2015-12-31 |
$91 |
2015-09-30 |
$93 |
2015-06-30 |
$104 |
2015-03-31 |
$4 |
2014-12-31 |
$2 |
2014-09-30 |
|
2014-06-30 |
|
2014-03-31 |
|
2013-12-31 |
$7 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical Instruments Manufacturing |
$2.836B |
$0.283B |
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally.
|